Trial intelligence / Profile preview

Valproate in Cocaine-Bipolar Comorbidity

NCT00240110Phase 2Completed

Sponsor
University of Miami
Start
Mar 2006
Primary completion
Mar 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in cocaine dependence and bipolar disorder (BD) comparing Placebo + Lithium with Valproate + Lithium (2 arms). Primary endpoint: Change From Baseline in Percentage of Cocaine-abstinent Days at 12 weeks. Started Mar 2006; status: completed.

02

Drugs

valproic acid
03

Conditions

cocaine dependencebipolar disorder (BD)

Beyond the preview

Go deeper on NCT00240110.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00240110.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call